DENVER, Nov. 8, 2011 /PRNewswire/ -- Quest Diagnostics joined the American Cancer Society today to encourage Denver-area residents to participate in the American Cancer Society's historic Cancer Prevention Study - 3 (CPS-3). The Denver enrollment period for this national, longitudinal study is between November 8 and 19, 2011. The CPS-3 Study focuses on uncovering the lifestyle, environmental and genetic factors that influence cancer risk by following 300,000 adults over the course of 20 years. The American Cancer Society and Quest Diagnostics are hoping to recruit approximately 1,000 Denver residents into the study.
"Quest Diagnostics applauds and thanks the American Cancer Society for pursuing the knowledge necessary to fight cancer for future generations, and we are proud to play a role in the important research that will inform that fight," said Laure Park, Vice President Communications and Investor Relations and Corporate Citizenship Officer for Quest Diagnostics. "We encourage Denver area residents to enroll in CPS-3, and join with us in supporting the American Cancer Society as they work to create more birthdays, both today and tomorrow."
To raise awareness of the CPS-3 Denver area November enrollment opportunity, Denver Nuggets Coach George Karl, Quest Diagnostics Denver Medical Director Ralph Giorno, M.D., and American Cancer Society CPS-3 Principal Investigator Alpa Patel, PhD, held a press conference today at the Quest Diagnostics Denver laboratory and patient service center, calling on the community to participate. Also in attendance was Diana Dreman, Miss Colorado, who has committed to a campaign in support of the American Cancer Society during her 2011 reign.
"We seek men and women between the ages of 30 and 65 who have never been diagnosed with cancer to participate in the CPS-3 study," said Dr. Patel. "A better understanding of the factors that contribute to cancer is the first step in our mission to cure c
|SOURCE Quest Diagnostics|
Copyright©2010 PR Newswire.
All rights reserved